Abstract: Biochip Array Technology (BAT) is a new technique used for screening purposes in clinical and forensic toxicology. The purpose of this article is to compare it with the standard ELISA with spectrophotometric detection (SD) in regard of its sensibility and specificity. Material and methods. Fifty five samples were analyzed on both BAT and ELISA SD; the results were confirmed using either GC-MS (for opiates, benzoilecgonine and cannabinoids) or HPLC (for barbiturates and benzodiazepines). Results. For opiates BAT technique had a sensibility of 100% and a specificity of 97.72%. Sensibility for ELISA SD technique was 92.3% and specificity 97.72%. For benzoilecgonine the sensibility and specificity for BAT was 100% whilst for ELISA SD the sensibility was 100% and specificity was 93.10%. For cannabinoids the sensibility for BAT was 90%, and specificity was 97.7% whilst for the ELISA SD technique the sensibility was 100% and the specificity was 91.11%. For barbiturates the sensibility and specificity was 100% for both methods. For benzodiazepines the sensibility for BAT was 100% and the specificity was 95.65% whilst for ELISA SD the sensibility was 100% and the specificity was 93.47%. Conclusions. The results obtained on BAT are comparable with those from ELISA-SD and have a high sensitivity and specificity compared to the used confirmatory methods. The results do not have however an increased statistical significance due to a very small number of positive results, caused by an abruptly decreasing number of positive cases in the last year, mainly due to increased used of "legal highs".
P reliminary screening for drugs is usually done on urine and, if not available, as in some forensic cases, on blood samples. BAT (Biochip Array Technology) is based on the principles of competitive ELISA [1] [2] [3] [4] [5] . The main difference between BAT and ELISA SD is that in the latter are used antibody coated wells whilst in BAT the reactions are taking place in a solid state device containing an array of discrete test regions with immobilized antibodies specific to different drugs. This new technique permits simultaneous screening of multiple analytes. It uses chemoiluminiscent reaction with luminol and a CCD (Charge Coupled Device) digital camera detection system termoelectric cooled to -50°C [6] [7] [8] [9] . ELISA SD is also a competitive enzyme immunoassay with spectrophotometric detection at 450 nm on microtitre strips [4, 5] . The purpose of this paper is to compare the two immunotechniques which may be used for drug screening on blood: ELISA with chemiluminiscence (Biochip Array Technology BAT) and ELISA with spectrophotometric detection (ELISA SD).
Material and methods
Fifty five samples of blood from postmortem and living persons were tested for opiates, benzoylecgonine, cannabinoids, barbiturates and benzodiazepines. The preliminary analytical test results were confirmed on GC-MS (opiates, benzoylecgonine, cannabinoids) and HPLC (barbiturates, benzodiazepines).
Laboratory equipment used: Evidence Investigator Immunoassay (RANDOX) for BAT, SIRIO S plate reader (SEAC) for ELISA SD. For confirmatory procedures we used GC-MS Agilent Technologies GC6890N MS5975B, with Column HP-5MS 30m x 0.25 mm x 0.25µm, and HPLC-DAD Agilent Technologies 1200, Column Lichrospher RP8ec, 5µm,250 x 4.0mm, Phenomenex.
Method. For the BAT technique we used DOA I WB SQ kits, and for the ELISA SD Cozart Forensic kits. For the GC-MS technique we used the following protocol: SPE, TFA + PFPOH derivatisation for opiates (morphine, codeine) and benzoylecgonine; SPE, derivatisation metilation for cannabinoids [3] . For the HPLC technique we used the following protocole: liquid-liquid extraction with dichlormethan / 1-clorbuthan, for barbiturates and benzodiazepine [1, 2] .
Data was included in a SPSS v.20 database; statistical analysis was conducted using the SPSS software and the graphical representations were done using the Microsoft Excel 2011 software.
Results
For opiates BAT identified 13 positive cases and 42 negative cases. ELISA SD has identified 14 positive cases and 41 negative cases. GC-MS was used as a confirmatory procedure and has identified 12 positive cases and 43 negative cases (Fig 1) . Sensibility for BAT technique was 100% and specificity was 97.72%. Sensibility for ELISA SD technique was 92.3% and specificity 97.72%. For benzoilecgonine ELISA SD has identified 5 positive cases and 50 negative cases, BAT one positive cases and 54 negative cases. GC-MS was used as a confirmatory procedure and gave one positive result and 54 negative results.
Sensibility and specificity for BAT was 100% whilst for ELISA SD sensibility was 100% and specificity was 93.10%. For cannabinoids BAT has identified ten positive cases and 44 negative cases, and ELISA SD has identified 14 positive cases and 40 negative cases (Fig 2) . GC-MS was used as a confirmatory procedure and gave ten positive results and 44 negative results. Sensibility for BAT was 90%, and specificity was 97.7% whilst for the ELISA SD technique the sensibility was 100% and the specificity was 91.11%. For benzodiazepines BAT gave 11 positive cases and 44 negative cases, and ELISA SD gave 12 positive cases and 43 negatives. HPLC was used as a confirmatory procedure and gave nine positive results and 46 negative results.
The sensibility for BAT was 100% and the specificity was 95.65% whilst for ELISA SD the sensibility was 100% and the specificity was 93.47%. For barbiturates both BAT and ELISA SD gave three positive results and 52 negatives. HPLC was used as a confirmatory procedure and gave three positive results and 52 negative results. Both BAT and ELISA had a sensibility and a specificity of 100%.
Discussions
Biochips are sets of miniaturized test sites arranges in a solid substrate in which are included a large number of biomolecules, allowing the simultaneous detection of hundreds or even thousands molecules in a few seconds. Nowadays BAT is increasingly used in nanotoxicology and molecular pathology, including coronary and myocardial diseases [9] [10] [11] , the responsiveness of various molecules to biologic and nonbiologic treatments [12, 13] , detection of adhesion molecules in the peripheral blood, detection of genetic mutations in colo-rectal cancer [14] , the profile of ßamiloid peptides in CSF in Alzheimer patients [15] , etc.
The results obtained on BAT are comparable with those from ELISA SD and have a high sensitivity and specificity compared to the reference methods (GC-MS for opiates, cannabinoids and benzoilecgonine, and HPLC for barbiturates and benzodiazepines). The results do not have however an increased statistical significance due to a very small number of positive results, caused by an abruptly decreasing number of positive cases in the last year, mainly due to increased use of "legal highs" [17] .
ELISA SD produced more false positive results than BAT especially for benzoilecgonine and cannabinoids; therefore, when suspecting one of these drugs he use of BAT seems recommended over the ELISA SD. Subsequently, the use of one technique over the other may be also influenced by the profile of drug consumption in a specific area -if cannabinoids and cocaine are the drugs most often used in a specific geographical area the use of BAT may be preferred as its use will decrease the number of false positives and the need for performing confirmatory procedures.
For barbiturates the number of positive cases was very low, making impossible any statistical analysis. Both immuno -echniques showed comparable results which allow preliminary screening important in legal medicine. BAT allows simultaneous detection of multiple analyses from a single blood sample, which means less time consuming and a smaller quantity of sample needed, making it the solution of choice if a cost-analysis is not performed.
Conclusion
Even if the BAT technique has a higher overall cost, it has the advantages of an increased efficiency, decreased analysis time, an increased specificity especially for cannabinoids and benzoilecgonine, and the possibility to test a higher number of molecules simultaneously (including conducting nontoxicological analysis like cytokines and adhesion molecules). 
